NutriBand (NTRB) Common Equity (2016 - 2026)
NutriBand (NTRB) posted Common Equity of $6.0 million for Q2 2026, down 10.32% sequentially from $6.7 million in Q1 2026, and up 17.37% YoY from $5.1 million in Q2 2025.
NutriBand (NTRB) Common Equity (2016 - 2026) Analysis & Trends
NutriBand has reported Common Equity for 11 years, with the latest figure at $6.0 million in Q2 2026.
- Quarterly Common Equity rose 17.37% year-over-year to $6.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $6.0 million (up 17.37% YoY) and the FY2026 annual result came in at $6.7 million, up 3.9% from the prior year.
- Common Equity retreated to $6.0 million in Q2 2026 per NTRB's latest filing, from $6.7 million in the prior quarter.
- Over five years, Common Equity peaked at $13.4 million in Q2 2024 and troughed at $5.1 million in Q2 2025.
- A 5-year average of $8.7 million and a median of $8.1 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity soared 96.66% in 2024, then slumped 61.81% in 2025.
- Over 5 years, Common Equity stood at $9.7 million in 2022, then tumbled by 41.31% to $5.7 million in 2023, then jumped by 96.66% to $11.2 million in 2024, then slumped by 32.79% to $7.5 million in 2025, then declined by 20.65% to $6.0 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $6.0 million, $6.7 million, and $7.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 5.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5.99 Mn |
| Jan 31, 2026 | 6.68 Mn |
| Oct 31, 2025 | 7.55 Mn |
| Jul 31, 2025 | 8.49 Mn |
| Apr 30, 2025 | 5.10 Mn |
| Jan 31, 2025 | 6.43 Mn |
| Oct 31, 2024 | 11.23 Mn |
| Jul 31, 2024 | 12.46 Mn |
| Apr 30, 2024 | 13.36 Mn |
| Jan 31, 2024 | 6.44 Mn |
| Oct 31, 2023 | 5.71 Mn |
| Jul 31, 2023 | 6.89 Mn |
| Apr 30, 2023 | 7.72 Mn |
| Jan 31, 2023 | 8.57 Mn |
| Oct 31, 2022 | 9.73 Mn |
| Jul 31, 2022 | 10.40 Mn |
| Apr 30, 2022 | 11.08 Mn |
| Jan 31, 2022 | 11.86 Mn |
| Oct 31, 2021 | 14.32 Mn |
| Jul 31, 2021 | 7.32 Mn |